Literature DB >> 23938216

Differential activation of myocardial ER stress response: a possible role in hypoxic tolerance.

Kanika Jain1, Geetha Suryakumar, Rajendra Prasad, Lilly Ganju.   

Abstract

BACKGROUND: Low oxygen availability in the high altitude milieu causes adverse physiological and pathological consequences to the cardiopulmonary system. A key role is played by proteins in maintaining optimal cardiac function under stress. Differential response to hypoxia may be linked to the susceptibility of proteins to free radical induced modifications. The present study was designed to understand the significance of protein oxidation and ER stress in the myocardial response to hostile environments.
METHODS: Sprague-Dawley rats were exposed to simulated hypoxia equivalent to 223 mmHg pressure, screened on the basis of time taken for onset of a characteristic hyperventilatory response and categorized as susceptible (<10 min), normal (10-25 min) or tolerant (>25 min). Protein modifications and activity of cellular proteolytic enzymes were assayed in myocardial tissue extracts to identify alterations in protein homeostasis. To evaluate the ER stress response, expression of various ER marker chaperones was investigated.
RESULTS: Susceptible animals displayed a distinct increase in protein oxidation and intracellular thiol content. They showed higher expression of ER stress hallmarks, GRP78, PDI and ERO1α, and exhibited a greater activation of the proteasome and calpain proteolytic systems, associated with elevated oxidized proteins. While a marked upregulation in the prosurvival signaling cascade PI3K/Akt/mTOR was observed in tolerant animals, the expression of pro-apoptotic caspase-3 and CHOP remained unaltered.
CONCLUSION: Thus, higher susceptibility to hypoxia is linked to a disruption in the proteostasis and activation of the ER stress response. Enhanced tolerance to hostile environments may be contributed by better maintenance of protein folding homeostasis.
© 2013.

Entities:  

Keywords:  ER stress; Heart; Hypobaric hypoxia; Proteostasis; Stress tolerance

Mesh:

Substances:

Year:  2013        PMID: 23938216     DOI: 10.1016/j.ijcard.2013.07.180

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

1.  Calpain-1 induces endoplasmic reticulum stress in promoting cardiomyocyte apoptosis following hypoxia/reoxygenation.

Authors:  Dong Zheng; Grace Wang; Shuai Li; Guo-Chang Fan; Tianqing Peng
Journal:  Biochim Biophys Acta       Date:  2015-02-04

2.  Oxidative protein modification alters proteostasis under acute hypobaric hypoxia in skeletal muscles: a comprehensive in vivo study.

Authors:  Akanksha Agrawal; Richa Rathor; Geetha Suryakumar
Journal:  Cell Stress Chaperones       Date:  2017-04-19       Impact factor: 3.667

Review 3.  Role of defective Ca2+ signaling in skeletal muscle weakness: Pharmacological implications.

Authors:  Akanksha Agrawal; Geetha Suryakumar; Richa Rathor
Journal:  J Cell Commun Signal       Date:  2018-07-07       Impact factor: 5.782

Review 4.  The interplay between autophagy and the ubiquitin-proteasome system in cardiac proteotoxicity.

Authors:  Changhua Wang; Xuejun Wang
Journal:  Biochim Biophys Acta       Date:  2014-08-01

5.  Differential hypoxic tolerance is mediated by activation of heat shock response and nitric oxide pathway.

Authors:  Kanika Jain; Geetha Suryakumar; Lilly Ganju; Shashi Bala Singh
Journal:  Cell Stress Chaperones       Date:  2014-03-04       Impact factor: 3.667

6.  Maternal nicotine exposure leads to impaired disulfide bond formation and augmented endoplasmic reticulum stress in the rat placenta.

Authors:  Michael K Wong; Catherine J Nicholson; Alison C Holloway; Daniel B Hardy
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

7.  Role of altered proteostasis network in chronic hypobaric hypoxia induced skeletal muscle atrophy.

Authors:  Akanksha Agrawal; Richa Rathor; Ravi Kumar; Geetha Suryakumar; Lilly Ganju
Journal:  PLoS One       Date:  2018-09-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.